These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 37387739)
1. Retracted: Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma. Markers D Dis Markers; 2023; 2023():9893453. PubMed ID: 37387739 [TBL] [Abstract][Full Text] [Related]
2. Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma. Wang W; Cui G; Zhao S Dis Markers; 2023; 2023():9155944. PubMed ID: 36845013 [TBL] [Abstract][Full Text] [Related]
3. Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death. Tang B; Xu W; Wang Y; Zhu J; Wang H; Tu J; Weng Q; Kong C; Yang Y; Qiu R; Zhao Z; Xu M; Ji J Clin Immunol; 2021 Nov; 232():108872. PubMed ID: 34648954 [TBL] [Abstract][Full Text] [Related]
4. Resveratrol improves the cytotoxic effect of CD8 +T cells in the tumor microenvironment by regulating HMMR/Ferroptosis in lung squamous cell carcinoma. Shan G; Minchao K; Jizhao W; Rui Z; Guangjian Z; Jin Z; Meihe L J Pharm Biomed Anal; 2023 May; 229():115346. PubMed ID: 37001272 [TBL] [Abstract][Full Text] [Related]
5. Systematic profiling of ferroptosis gene signatures predicts prognostic factors in esophageal squamous cell carcinoma. Lu T; Xu R; Li Q; Zhao JY; Peng B; Zhang H; Guo JD; Zhang SQ; Li HW; Wang J; Zhang LY Mol Ther Oncolytics; 2021 Jun; 21():134-143. PubMed ID: 33981829 [TBL] [Abstract][Full Text] [Related]
6. Systematic analysis of ferroptosis-related long non-coding RNA predicting prognosis in patients with lung squamous cell carcinoma. Yao N; Zuo L; Yan X; Qian J; Sun J; Xu H; Zheng F; Efird JT; Kawagoe I; Wang Y; Ni S Transl Lung Cancer Res; 2022 Apr; 11(4):632-646. PubMed ID: 35529787 [TBL] [Abstract][Full Text] [Related]
7. Retracted: Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma. International BR Biomed Res Int; 2022; 2022():9829634. PubMed ID: 36605105 [TBL] [Abstract][Full Text] [Related]
8. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma. He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150 [TBL] [Abstract][Full Text] [Related]
9. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes. Diao X; Guo C; Liu L; Wang G; Li S Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420 [TBL] [Abstract][Full Text] [Related]
10. Retracted: Identification of Ferroptosis-Related Long Noncoding RNA and Construction of a Novel Prognostic Signature for Gastric Cancer. Markers D Dis Markers; 2023; 2023():9810178. PubMed ID: 37387742 [TBL] [Abstract][Full Text] [Related]
11. m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma. Pan J; Huang Z; Xu Y Front Oncol; 2021; 11():657466. PubMed ID: 34195072 [TBL] [Abstract][Full Text] [Related]
12. A Ferroptosis-Related Prognostic Signature Based on Antitumor Immunity and Tumor Protein p53 Mutation Exploration for Guiding Treatment in Patients With Head and Neck Squamous Cell Carcinoma. Fan X; Ou Y; Liu H; Zhan L; Zhu X; Cheng M; Li Q; Yin D; Liao L Front Genet; 2021; 12():732211. PubMed ID: 34616431 [No Abstract] [Full Text] [Related]
13. Prognostic Signatures Based on Ferroptosis- and Immune-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma. Xing C; Yin H; Yao ZY; Xing XL Front Oncol; 2021; 11():774558. PubMed ID: 35087751 [TBL] [Abstract][Full Text] [Related]
14. Retracted: Identification of Therapeutic Targets and Prognostic Biomarkers among Genes from the Mediator Complex Family in the Hepatocellular Carcinoma Tumour-Immune Microenvironment. Methods In Medicine CAM Comput Math Methods Med; 2023; 2023():9760920. PubMed ID: 38094413 [TBL] [Abstract][Full Text] [Related]
15. A ferroptosis-related gene signature for overall survival prediction and immune infiltration in lung squamous cell carcinoma. Miao TW; Yang DQ; Chen FY; Zhu Q; Chen X Biosci Rep; 2022 Aug; 42(8):. PubMed ID: 35866375 [TBL] [Abstract][Full Text] [Related]
16. Ferroptosis-Related Genes Are Potential Therapeutic Targets and the Model of These Genes Influences Overall Survival of NSCLC Patients. Zhang N; Wu Y; Wu Y; Wang L; Chen J; Wang X; Chard Dunmall LS; Cheng Z; Wang Y Cells; 2022 Jul; 11(14):. PubMed ID: 35883650 [TBL] [Abstract][Full Text] [Related]
17. Ferroptosis-related local immune cytolytic activity in tumor microenvironment of basal cell and squamous cell carcinoma. Wang J; Xie D; Wu H; Li Y; Wan C Aging (Albany NY); 2022 May; 14(9):3956-3972. PubMed ID: 35501667 [TBL] [Abstract][Full Text] [Related]
18. Retracted: Identification of Novel Biomarkers Related to Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis. Methods In Medicine CAM Comput Math Methods Med; 2023; 2023():9780526. PubMed ID: 38094439 [TBL] [Abstract][Full Text] [Related]
19. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis. Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405 [TBL] [Abstract][Full Text] [Related]
20. Ferroptosis-related lncRNAs signature to predict the survival and immune evasion for lung squamous cell carcinoma. Zhang R; Zhang X; Yang H; Lin Y; Wen Y; Zhao D; Chen L; Lin P; Zhang L Front Genet; 2022; 13():968601. PubMed ID: 36092894 [No Abstract] [Full Text] [Related] [Next] [New Search]